BACKGROUND
The aim of this study was to assess the role of skin rash in predicting the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and the prognosis of patients with non-small cell lung cancer (NSCLC).
METHOD
We systematically searched for eligible articles investigating the association between rash and the efficacy of EGFR-TKIs and the prognosis of pat...
